Neuroprotective activation of astrocytes by methylmercury exposure in the inferior colliculus.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 09 2019
25 09 2019
Historique:
received:
09
05
2019
accepted:
11
09
2019
entrez:
27
9
2019
pubmed:
27
9
2019
medline:
28
10
2020
Statut:
epublish
Résumé
Methylmercury (MeHg) is well known to induce auditory disorders such as dysarthria. When we performed a global analysis on the brains of mice exposed to MeHg by magnetic resonance imaging, an increase in the T1 signal in the inferior colliculus (IC), which is localized in the auditory pathway, was observed. Therefore, the purpose of this study is to examine the pathophysiology and auditory dysfunction induced by MeHg, focusing on the IC. Measurement of the auditory brainstem response revealed increases in latency and decreases in threshold in the IC of mice exposed to MeHg for 4 weeks compared with vehicle mice. Incoordination in MeHg-exposed mice was noted after 6 weeks of exposure, indicating that IC dysfunction occurs earlier than incoordination. There was no change in the number of neurons or microglial activity, while the expression of glial fibrillary acidic protein, a marker for astrocytic activity, was elevated in the IC of MeHg-exposed mice after 4 weeks of exposure, indicating that astrogliosis occurs in the IC. Suppression of astrogliosis by treatment with fluorocitrate exacerbated the latency and threshold in the IC evaluated by the auditory brainstem response. Therefore, astrocytes in the IC are considered to play a protective role in the auditory pathway. Astrocytes exposed to MeHg increased the expression of brain-derived neurotrophic factor in the IC, suggesting that astrocytic brain-derived neurotrophic factor is a potent protectant in the IC. This study showed that astrogliosis in the IC could be an adaptive response to MeHg toxicity. The overall toxicity of MeHg might be determined on the basis of the balance between MeHg-mediated injury to neurons and protective responses from astrocytes.
Identifiants
pubmed: 31554907
doi: 10.1038/s41598-019-50377-9
pii: 10.1038/s41598-019-50377-9
pmc: PMC6761145
doi:
Substances chimiques
Brain-Derived Neurotrophic Factor
0
Glial Fibrillary Acidic Protein
0
Methylmercury Compounds
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13899Références
Toxicology. 2001 Apr 12;162(1):11-22
pubmed: 11311454
Nat Commun. 2017 Jun 22;8(1):28
pubmed: 28642575
J Clin Biochem Nutr. 2016 Nov;59(3):182-190
pubmed: 27895385
Toxicol Lett. 1986 Mar;30(3):267-71
pubmed: 3705108
Free Radic Biol Med. 2009 Aug 15;47(4):449-57
pubmed: 19450679
Biochem Pharmacol. 1993 Aug 3;46(3):525-34
pubmed: 8394084
Acta Neuropathol. 2010 Jan;119(1):7-35
pubmed: 20012068
J Biol Chem. 2015 Sep 11;290(37):22805-17
pubmed: 26231211
Brain Res. 1990 Jun 25;521(1-2):221-8
pubmed: 2207661
Brain Res. 2007 Feb 2;1131(1):1-10
pubmed: 17182013
J Pediatr. 2004 Feb;144(2):177-83
pubmed: 14760257
Toxicol Lett. 2008 Feb 15;176(3):188-97
pubmed: 18191348
Brain Res. 2016 Dec 1;1652:1-13
pubmed: 27693413
Toxicol Pathol. 1997 Nov-Dec;25(6):614-23
pubmed: 9437807
Am J Pathol. 1967 Oct;51(4):573-90
pubmed: 4227946
Curr Protoc Neurosci. 2006 Feb;Chapter 8:Unit8.21B
pubmed: 18428645
Crit Rev Toxicol. 2008;38(5):463-71
pubmed: 18568866
J Toxicol Environ Health A. 2017;80(19-21):1145-1155
pubmed: 28850017
Brain Res. 1992 Mar 27;576(1):120-4
pubmed: 1515906
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
Acta Neuropathol. 1985;67(1-2):13-24
pubmed: 4024866
J Toxicol Environ Health A. 2012;75(16-17):1091-101
pubmed: 22852858
Acta Neuropathol. 2008 Oct;116(4):447-52
pubmed: 18521615
Sci Rep. 2017 Jul 24;7(1):6268
pubmed: 28740157
J Neurosci. 2015 Mar 4;35(9):3794-805
pubmed: 25740510
J Occup Environ Med. 2003 Jan;45(1):87-95
pubmed: 12553183
Brain Res. 2008 Nov 6;1239:207-15
pubmed: 18801347
Glia. 2011 May;59(5):810-20
pubmed: 21351162
Sci Rep. 2014 Mar 10;4:4329
pubmed: 24710318
Glia. 2002 Jan;37(1):43-52
pubmed: 11746782
J Toxicol Sci. 2012;37(4):749-63
pubmed: 22863855
Hear Res. 2012 Jun;288(1-2):47-57
pubmed: 22343068
Toxicol Appl Pharmacol. 2008 Feb 15;227(1):147-54
pubmed: 18023834
Physiol Rev. 2010 Jul;90(3):983-1012
pubmed: 20664077
Toxicol Pathol. 2001 Sep-Oct;29(5):565-73
pubmed: 11695574
Brain Res. 1988 Oct 11;462(1):31-9
pubmed: 3179736
Mol Chem Neuropathol. 1997 Aug;31(3):225-33
pubmed: 9336765
Brain Res. 2007 May 25;1147:272-83
pubmed: 17349980
Mol Cell Biochem. 2007 Sep;303(1-2):73-81
pubmed: 17410406
Environ Toxicol Pharmacol. 2015 Jul;40(1):199-205
pubmed: 26143513
Toxicol Appl Pharmacol. 2000 Aug 1;166(3):203-13
pubmed: 10906284
Biol Trace Elem Res. 2003 Oct;95(1):1-10
pubmed: 14555794
PLoS One. 2013;8(2):e57898
pubmed: 23469098
Acta Pathol Jpn. 1982;32 Suppl 1:73-99
pubmed: 6765001
Acta Neuropathol. 1989;77(6):561-8
pubmed: 2750475